Cargando…
Metformin Promotes Beclin1-Dependent Autophagy to Inhibit the Progression of Gastric Cancer
BACKGROUND: Metformin is the first-line blood sugar control drug for type 2 diabetes, but recent epidemiological studies have shown that it inhibits the growth of a variety of tumours. However, few studies have examined metformin effects on gastric cancer (GC), and the anticancer mechanism has not b...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245468/ https://www.ncbi.nlm.nih.gov/pubmed/32547075 http://dx.doi.org/10.2147/OTT.S242298 |